282 related articles for article (PubMed ID: 25335433)
1. Regulatory T cells from active non-segmental vitiligo exhibit lower suppressive ability on CD8+CLA+ T cells.
Lin M; Zhang BX; Shen N; Dong XJ; Zhang C; Qi XY; Zhu J; Li YZ; Man MQ; Tu CX
Eur J Dermatol; 2014; 24(6):676-82. PubMed ID: 25335433
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of peripheral regulatory T-cell suppression of skin-homing CD8⁺T cells in atopic dermatitis.
Zhang BX; Lyu JC; Liu HB; Feng DQ; Zhang DC; Bi XJ; Duan ZW; Ding G
Yonsei Med J; 2015 Jan; 56(1):196-203. PubMed ID: 25510765
[TBL] [Abstract][Full Text] [Related]
3. Levels of TGF-β(1) in serum and culture supernatants of CD4(+)CD25 (+) T cells from patients with non-segmental vitiligo.
Tu CX; Jin WW; Lin M; Wang ZH; Man MQ
Arch Dermatol Res; 2011 Nov; 303(9):685-9. PubMed ID: 21644048
[TBL] [Abstract][Full Text] [Related]
4. Characterization of circulating CD8+T cells expressing skin homing and cytotoxic molecules in active non-segmental vitiligo.
Zhang BX; Lin M; Qi XY; Zhang RX; Wei ZD; Zhu J; Man MQ; Tu CX
Eur J Dermatol; 2013; 23(3):331-8. PubMed ID: 23782916
[TBL] [Abstract][Full Text] [Related]
5. Reduction of skin-homing cytotoxic T cells (CD8+ -CLA+) in patients with vitiligo.
Antelo DP; Filgueira AL; Cunha JM
Photodermatol Photoimmunol Photomed; 2011 Feb; 27(1):40-4. PubMed ID: 21198882
[TBL] [Abstract][Full Text] [Related]
6. Decreased suppression of CD8
Giri PS; Dwivedi M; Begum R
Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
[TBL] [Abstract][Full Text] [Related]
7. HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1.
Lang KS; Caroli CC; Muhm A; Wernet D; Moris A; Schittek B; Knauss-Scherwitz E; Stevanovic S; Rammensee HG; Garbe C
J Invest Dermatol; 2001 Jun; 116(6):891-7. PubMed ID: 11407977
[TBL] [Abstract][Full Text] [Related]
8. Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo.
Lili Y; Yi W; Ji Y; Yue S; Weimin S; Ming L
PLoS One; 2012; 7(5):e37513. PubMed ID: 22649532
[TBL] [Abstract][Full Text] [Related]
9. TGF-β1 contributes to CD8+ Treg induction through p38 MAPK signaling in ovarian cancer microenvironment.
Wu M; Chen X; Lou J; Zhang S; Zhang X; Huang L; Sun R; Huang P; Wang F; Pan S
Oncotarget; 2016 Jul; 7(28):44534-44544. PubMed ID: 27322208
[TBL] [Abstract][Full Text] [Related]
10. Assessment of tissue FoxP3+, CD4+ and CD8+ T-cells in active and stable nonsegmental vitiligo.
Abdallah M; Lotfi R; Othman W; Galal R
Int J Dermatol; 2014 Aug; 53(8):940-6. PubMed ID: 24527781
[TBL] [Abstract][Full Text] [Related]
11. Increased circulating Th17 cells and elevated serum levels of TGF-beta and IL-21 are correlated with human non-segmental vitiligo development.
Zhou L; Shi YL; Li K; Hamzavi I; Gao TW; Huggins RH; Lim HW; Mi QS
Pigment Cell Melanoma Res; 2015 May; 28(3):324-9. PubMed ID: 25604047
[TBL] [Abstract][Full Text] [Related]
12. The suppressive function of human CD8(+) iTregs is inhibited by IL-1β and TNFα.
Bjarnadottir U; Lemarquis AL; Halldorsdottir S; Freysdottir J; Ludviksson BR
Scand J Immunol; 2014 Nov; 80(5):313-22. PubMed ID: 25039313
[TBL] [Abstract][Full Text] [Related]
13. Alteration in regulatory T cells and programmed cell death 1-expressing regulatory T cells in active generalized vitiligo and their clinical correlation.
Tembhre MK; Parihar AS; Sharma VK; Sharma A; Chattopadhyay P; Gupta S
Br J Dermatol; 2015 Apr; 172(4):940-50. PubMed ID: 25376752
[TBL] [Abstract][Full Text] [Related]
14. T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo.
Tembhre MK; Sharma VK; Sharma A; Chattopadhyay P; Gupta S
Clin Chim Acta; 2013 Sep; 424():27-32. PubMed ID: 23680073
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
Bocian K; Borysowski J; Wierzbicki P; Wyzgal J; Klosowska D; Bialoszewska A; Paczek L; Górski A; Korczak-Kowalska G
Nephrol Dial Transplant; 2010 Mar; 25(3):710-7. PubMed ID: 19903662
[TBL] [Abstract][Full Text] [Related]
17. Compromised melanocyte survival due to decreased suppression of CD4
Shah F; Giri PS; Bharti AH; Dwivedi M
Exp Dermatol; 2024 Jan; 33(1):e14982. PubMed ID: 37994568
[TBL] [Abstract][Full Text] [Related]
18. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
[TBL] [Abstract][Full Text] [Related]
20. The role of helper and regulatory T cells in the pathogenesis of vitiligo.
Basak PY; Adiloglu AK; Ceyhan AM; Tas T; Akkaya VB
J Am Acad Dermatol; 2009 Feb; 60(2):256-60. PubMed ID: 19022528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
